These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7531708)
21. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Chambers TC; Zheng B; Kuo JF Mol Pharmacol; 1992 Jun; 41(6):1008-15. PubMed ID: 1377325 [TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor. Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779 [TBL] [Abstract][Full Text] [Related]
23. Secretagogue regulation of pancreatic acinar cell protein phosphorylation shown by large-scale 2D-PAGE. Wishart MJ; Groblewski G; Göke BJ; Wagner AC; Williams JA Am J Physiol; 1994 Oct; 267(4 Pt 1):G676-86. PubMed ID: 7943332 [TBL] [Abstract][Full Text] [Related]
24. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [TBL] [Abstract][Full Text] [Related]
25. CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Berna MJ; Hoffmann KM; Tapia JA; Thill M; Pace A; Mantey SA; Jensen RT Biochim Biophys Acta; 2007 Apr; 1773(4):483-501. PubMed ID: 17306383 [TBL] [Abstract][Full Text] [Related]
26. A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini. Schäfer C; Ross SE; Bragado MJ; Groblewski GE; Ernst SA; Williams JA J Biol Chem; 1998 Sep; 273(37):24173-80. PubMed ID: 9727040 [TBL] [Abstract][Full Text] [Related]
27. Carbachol regulates cholecystokinin receptor on pancreatic acinar cells. Honda T; Adachi H; Noguchi M; Sato S; Onishi S; Aoki E; Torizuka K Am J Physiol; 1987 Jan; 252(1 Pt 1):G77-83. PubMed ID: 3101510 [TBL] [Abstract][Full Text] [Related]
28. Carbachol acts through protein kinase C to modulate cholecystokinin receptors on pancreatic acini. Louie DS; Chung OY Am J Physiol; 1991 Dec; 261(6 Pt 1):G981-6. PubMed ID: 1722647 [TBL] [Abstract][Full Text] [Related]
29. Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cells. Lutz MP; Pinon DI; Gates LK; Shenolikar S; Miller LJ J Biol Chem; 1993 Jun; 268(16):12136-42. PubMed ID: 8389371 [TBL] [Abstract][Full Text] [Related]
30. Intracellular mechanisms involved in short-term regulation of net protein synthesis in pancreatic acini. Perkins PS; Bahrami LH; Lenhard LW; Pandol SJ Biochim Biophys Acta; 1991 Apr; 1092(2):145-52. PubMed ID: 1708286 [TBL] [Abstract][Full Text] [Related]
31. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini. Tsunoda Y; Owyang C Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841 [TBL] [Abstract][Full Text] [Related]
32. Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini. Duan RD; Zheng CF; Guan KL; Williams JA Am J Physiol; 1995 Jun; 268(6 Pt 1):G1060-5. PubMed ID: 7611406 [TBL] [Abstract][Full Text] [Related]
33. Specificity of phospholipase D activation by cholecystokinin and phorbol myristate acetate but not by carbamylcholine and A23187 in rat pancreatic acini. Rydzewska G; Morisset J Digestion; 1995; 56(2):127-36. PubMed ID: 7750666 [TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin-stimulated tyrosine phosphorylation of p125FAK and paxillin is mediated by phospholipase C-dependent and -independent mechanisms and requires the integrity of the actin cytoskeleton and participation of p21rho. García LJ; Rosado JA; González A; Jensen RT Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):461-72. PubMed ID: 9359417 [TBL] [Abstract][Full Text] [Related]
35. The effect of protein kinase-C inhibition on insulin receptor phosphorylation. Duronio V; Jacobs S Endocrinology; 1990 Jul; 127(1):481-7. PubMed ID: 2193799 [TBL] [Abstract][Full Text] [Related]
36. The effect of concomitant stimulation with cholecystokinin and epidermal growth factor on extracellular signal-regulated kinase (ERK) activity in pancreatic acinar cells. Daniluk J; Dabrowski A J Physiol Pharmacol; 2007 Sep; 58(3):441-53. PubMed ID: 17928641 [TBL] [Abstract][Full Text] [Related]
37. Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. Roettger BF; Rentsch RU; Hadac EM; Hellen EH; Burghardt TP; Miller LJ J Cell Biol; 1995 Aug; 130(3):579-90. PubMed ID: 7622559 [TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin and EGF activate a MAPK cascade by different mechanisms in rat pancreatic acinar cells. Dabrowski A; Groblewski GE; Schäfer C; Guan KL; Williams JA Am J Physiol; 1997 Nov; 273(5):C1472-9. PubMed ID: 9374631 [TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of the 48-kDa subunit of the glycine receptor by protein kinase C. Ruiz-Gómez A; Vaello ML; Valdivieso F; Mayor F J Biol Chem; 1991 Jan; 266(1):559-66. PubMed ID: 1845981 [TBL] [Abstract][Full Text] [Related]
40. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor. Ghanekar D; Hadac EM; Holicky EL; Miller LJ J Pharmacol Exp Ther; 1997 Sep; 282(3):1206-12. PubMed ID: 9316827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]